Rituximab in heavily pretreated cutaneous B-cell lymphoma

被引：7
|
作者：
Zinzani, PL [1 ]
Stefoni, V [1 ]
Alinari, L [1 ]
Vianelli, N [1 ]
Baccarani, M [1 ]
机构：
[1] Univ Bologna, Inst Hematol & Med Oncol Le A Seragnoli, Policlin S Orsola, I-40138 Bologna, Italy
来源：
LEUKEMIA & LYMPHOMA | 2003年 / 44卷 / 09期
关键词：
D O I：
10.1080/1042819031000104024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1637 / 1638
页数：2
相关论文
共 50 条
  • [1] Intralesional rituximab for cutaneous B-cell lymphoma
    Paul, T
    Radny, P
    Kröber, SM
    Paul, A
    Blaheta, HJ
    Garbe, C
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) : 1239 - 1243
  • [2] Everolimus in Combination with Rituximab Induces Complete Responses in Heavily Pretreated Diffuse Large B-Cell Lymphoma
    Barnes, Jeffrey A.
    Jacobsen, Eric
    Feng, Yang
    Freedman, Arnold S.
    Hochberg, Ephraim P.
    LaCasce, Ann S.
    Armand, Philippe
    Joyce, Robin
    Neuberg, Donna
    Fisher, David C.
    Abramson, Jeremy S.
    BLOOD, 2011, 118 (21) : 710 - 711
  • [3] Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma
    Barnes, Jeffrey A.
    Jacobsen, Eric
    Feng, Yang
    Freedman, Arnold
    Hochberg, Ephraim P.
    LaCasce, Ann S.
    Armand, Philippe
    Joyce, Robin
    Sohani, Aliyah R.
    Rodig, Scott J.
    Neuberg, Donna
    Fisher, David C.
    Abramson, Jeremy S.
    HAEMATOLOGICA, 2013, 98 (04) : 615 - 619
  • [4] Cutaneous B-cell lymphoma treated with rituximab infusions
    Schneider, Lars Alexander
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (06) : 550 - 551
  • [5] Rituximab treatment in primary cutaneous B-cell lymphoma
    Estrach, M. Teresa
    Lerma, Ingrid Lopez
    Herrera, Adriana Garcia
    Mascaro, Jose Manuel, Jr.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB138 - AB138
  • [6] Treatment of primary cutaneous B-cell lymphoma with rituximab
    Fink-Puches, R
    Wolf, IH
    Zalaudek, I
    Kerl, H
    Cerroni, L
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (05) : 847 - 853
  • [7] Panobinostat in Combination with Rituximab in Heavily Pretreated Diffuse Large B-Cell Lymphoma: Results of a Phase II Study
    Barnes, Jeffrey A.
    Redd, Robert Allyn
    Jacobsen, Eric D.
    Fisher, David C.
    Freedman, Arnold S.
    Hochberg, Ephraim P.
    Takvorian, Tak
    Neuberg, Donna
    Abramson, Jeremy S.
    BLOOD, 2014, 124 (21)
  • [8] Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II study
    Barnes, Jeffrey A.
    Redd, Robert
    Fisher, David C.
    Hochberg, Ephraim P.
    Takvorian, Tak
    Neuberg, Donna
    Jacobsen, Eric
    Abramson, Jeremy S.
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (04) : 633 - 637
  • [9] CUTANEOUS MARGINAL ZONE B-CELL LYMPHOMA TREATED WITH RITUXIMAB
    Pedraz, Javier
    Delgado, Yolanda
    Aragues, Maximiliano
    Fraga, Javier
    Garcia-Diez, Amaro
    Fernandez-Herrera, Jesus
    ACTAS DERMO-SIFILIOGRAFICAS, 2005, 96 (09): : 593 - 597
  • [10] Intralesional rituximab for indolent primary cutaneous B-cell lymphoma
    Besch-Stokes, Jake
    Bhullar, Puneet
    Puri, Pranav
    Boudreaux, Blake
    Costello, Collin
    Rule, William
    Rosenthal, Allison
    DiCaudo, David J.
    Pittelkow, Mark R.
    Mangold, Aaron
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB177 - AB177
12345